Potential risk for drug resistance globalization at the Hajj

Clinical Microbiology and Infection

Volumn 21, Issue 2, 2015, Pages 109-114

  Al Tawfiq, J A ^a,b   Memish, Z A ^c,d  

^a DHAHRAN HEALTH CENTER   (Saudi Arabia)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MINISTRY OF HEALTH   (Saudi Arabia)

^d ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Antibiotic; Bacterial transmission; Drug resistant organism; Hajj; Mass gathering; Saudi Arabia

Indexed keywords

ANTIBIOTIC RESISTANCE; BLOODBORNE BACTERIUM; DISEASE TRANSMISSION; HUMAN; LUNG TUBERCULOSIS; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRAVEL; BACTERIAL INFECTIONS; BACTERIUM; CROWDING (AREA); DRUG EFFECTS; HEALTH; MICROBIOLOGY; RELIGION; RISK ASSESSMENT; SAUDI ARABIA; TRANSMISSION;

BACTERIA (MICROORGANISMS);

BACTERIA; BACTERIAL INFECTIONS; CROWDING; DISEASE TRANSMISSION, INFECTIOUS; DRUG RESISTANCE, BACTERIAL; GLOBAL HEALTH; HUMANS; RELIGION AND MEDICINE; RISK ASSESSMENT; SAUDI ARABIA;

EID: 84923058246     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2014.11.013     Document Type: Review

References (54)

1. Memish Z.A., Zumla A., Alhakeem R.F., Assiri A., Turkestani A., Al Harby K.D., et al. Hajj: infectious disease surveillance and control. Lancet 2014, 383:2073-2082.
2. Ahmed Q.A., Arabi Y.M., Memish Z.A. Health risks at the Hajj. Lancet 2006, 367:1008-1015.
3. Al-Tawfiq J.A., Memish Z.A. Mass gathering medicine: 2014 Hajj and Umra preparation as a leading example. JInfect Dis 2014, 27C:26-31.
4. Al-Tawfiq J.A., Memish Z.A. Mass gatherings and infectious diseases: prevention, detection, and control. Infect Dis Clin North Am 2012, 26:725-737.
5. Bell M. Antibiotic misuse: a global crisis. JAMA Intern Med 2014, 174:1920-1921.
6. Qureshi H., Gessner B.D., Leboulleux D., Hasan H., Alam S.E., Moulton L.H. The incidence of vaccine preventable influenza-like illness and medication use among Pakistani pilgrims to the Haj in Saudi Arabia. Vaccine 2000, 18:2956-2962.
7. Mustafa A.N., Gessner B.D., Ismail R., Yusoff A.F., Abdullah N., Ishak I., et al. Acase-control study of influenza vaccine effectiveness among Malaysian pilgrims attending the Haj in Saudi Arabia. Int J Infect Dis 2003, 7:210-214.
8. Alborzi A., Oskoee S., Pourabbas B., Alborzi S., Astaneh B., Gooya M.M., et al. Meningococcal carrier rate before and after Hajj pilgrimage: effect of single dose ciprofloxacin on carriage. East Mediterr Health J 2008, 14:277-282.
9. Husain E.H., Dashti A.A., Electricwala Q.Y., Abdulsamad A.M., Al-Sayegh S. Absence of Neisseria meningitidis from throat swabs of Kuwaiti pilgrims after returning from the Hajj. Med Princ Pract 2010, 19:321-323.
10. Al-Tawfiq J.A., Memish Z.A. The Hajj: updated health hazards and current recommendations for 2012. Euro Surveill 2012, 17:20295.
11. Al-Tawfiq J.A., Stephens G., Memish Z.A. Inappropriate antimicrobial use and potential solutions: a Middle Eastern perspective. Expert Rev Anti Infect Ther 2010, 8:765-774.
12. Lee L.A., Ostroff S.M., McGee H.B., Johnson D.R., Downes F.P., Cameron D.N., et al. An outbreak of shigellosis at an outdoor music festival. Am J Epidemiol 1991, 133:608-615.
13. Okeke I.N., Edelman R. Dissemination of antibiotic-resistant bacteria across geographic borders. Clin Infect Dis 2001, 33:364-369.
14. Nordmann P., Poirel L., Walsh T.R., Livermore D.M. The emerging NDM carbapenemases. Trends Microbiol 2011, 19:588-595.
15. Batchelor M., Hopkins K., Threlfall E.J., Clifton-Hadley F.A., Stallwood A.D., Davies R.H., et al. blaCTX-M genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003. Antimicrob Agents Chemother 2005, 49:1319-1322.
16. Kim S., Hu J., Gautom R., Kim J., Lee B., Boyle D.S. CTX-M extended-spectrum β-lactamases, Washington State. Emerg Infect Dis 2007, 13:513-514.
17. Al Naiemi N., Zwart B., Rijnsburger M.C., Roosendaal R., Debets-Ossenkopp Y.J., Mulder J.A., et al. Extended spectrum-β-lactamase production in a Salmonella enterica serotype Typhi strain from the Philippines. JClin Microbiol 2008, 46:2794-2795.
18. Sirichote P., Hasman H., Pulsrikarn C., Schønheyder H.C., Samulioniené J., Pornruangmong S., et al. Molecular characterization of extended-spectrum cephalosporinase-producing Salmonella enterica serovar Choleraesuis isolates from patients in Thailand and Denmark. JClin Microbiol 2010, 48:883-888.
19. van der Bij A.K., Pitout J.D. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. JAntimicrob Chemother 2012, 67:2090-2100.
20. Wharton M., Spiegel R.A., Horan J.M., Tauxe R.V., Wells J.G., Barg N., et al. Alarge outbreak of antibiotic-resistant shigellosis at a mass gathering. JInfect Dis 1990, 162:1324-1328.
21. Memish Z.A., Assiri Abdullah, Almasri M., Alhakeem R.F., Turkestani A., Al Rabeeah A.A., et al. Impact of the Hajj on pneumococcal transmission. Clin Microbiol Infect 2015, 21:77.e11-77.e18.
22. Benkouiten S., Charrel R., Belhouchat K., Drali T., Nougairede A., Salez N., et al. Respiratory viruses and bacteria among Pilgrims during the 2013 Hajj. Emerg Infect Dis 2014, 20:1821-1827.
23. Memish Z.A., Ahmed Q.A. Mecca bound: the challenges ahead. JTravel Med 2002, 9:202-210.
24. ZA1 Memish, Balkhy H.H., Almuneef M.A., Al-Haj-Hussein B.T., Bukhari A.I., Osoba A.O. Carriage of Staphylococcus aureus among Hajj pilgrims. Saudi Med J 2006, 27:1367-1372.
25. Shukla S.K. Community-associated methicillin-resistant Staphylococcus aureus and its emerging virulence. Clin Med Res 2005, 3:57-60.
26. Dablool A.S., Al-Ghamdi S.S. Enterotoxigenicity of Staphylococcus aureus isolated from food handlers during Hajj season in Saudi Arabia. Open J Safety Sci Technol 2011, 1:75-78.
27. Johargy A., Sorour A.E., Momenah A.M., Asghar A., Alherabi A., Elsayed H. Prevalence of nasal carriage of Staphylococcus aureus among Umrah visitors and pilgrims during Umrah and Hajj seasons. Egyptian J Med Microbiol 2011, 20:162-166.
28. Ashgar S.S., El-Said H.M., Johargy A., Am Momenah, Asghar A., Sorour A.E., et al. Prevalence of nasal carriage of Neisseria meningitidis among Umrah visitors and pilgrims during Umrah and Hajj season. Global Advan Res J Microbiol 2013, 2:141-149.
29. Al-Tawfiq J.A., Zumla A., Memish Z.A. Respiratory tract infections during the annual Hajj: potential risks and mitigation strategies. Curr Opin Pulm Med 2013, 19:192-197.
30. Al-Orainey I.O. Tuberculosis infection during Hajj pilgrimage. The risk to pilgrims and their communities. Saudi Med J 2013, 34:676-680.
31. Wilder-Smith A., Foo W., Earnest A., Paton N.I. High risk of Mycobacterium tuberculosis infection during the Hajj pilgrimage. Trop Med Int Health 2005, 10:336-339.
32. Alzeer A., Mashlah A., Fakim N., Al-Sugair N., Al-Hedaithy M., Al-Majed S., et al. Tuberculosis is the commonest cause of pneumonia requiring hospitalization during Hajj (pilgrimage to Makkah). JInfect 1998, 36:303-306.
33. Madani T.A., Ghabrah T.M., Al-Hedaithy M.A., Alhazmi M.A., Alazraqi T.A., Albarrak A.M., et al. Causes of hospitalization of pilgrims in the Hajj season of the Islamic year 1423 (2003). Ann Saudi Med 2006, 26:346-351.
34. Madani T.A., Ghabrah T.M., Albarrak A.M., Alhazmi M.A., Alazraqi T.A., Althaqafi A.O., et al. Causes of admission to intensive care units in the Hajj period of the Islamic year 1424 (2004). Ann Saudi Med 2007, 27:101-105.
35. Mandourah Y., Al-Radi A., Ocheltree A.H., Ocheltree S.R., Fowler R.A. Clinical and temporal patterns of severe pneumonia causing critical illness during Hajj. BMC Infect Dis 2012, 16(12):117.
36. El-Sheikh S.M., El-Assouli S.M., Mohammed K.A., Albar M. Bacteria and viruses that cause respiratory tract infections during the pilgrimage (Haj) season in Mecca, Saudi Arabia. Trop Med Int Health 1998, 3:205-209.
37. Khan M.Y., Kinsara A.J., Osoba A.O., Wali S., Samman Y., Memish Z. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia. Int J Antimicrob Agents 2001, 17:415-418.
38. Al-Kassimi F.A., Abdullah A.K., Al-Hajjaj M.S., Al-Orainey I.O., Bamgboye E.A., Chowdhury M.N. Nationwide community survey of tuberculosis epidemiology in Saudi Arabia. Tuber Lung Dis 1993, 74:254-260.
39. Alzeer A.H. Respiratory tract infection during Hajj. Ann Thorac Med 2009, 4:50-53.
40. Yezli S., Memish Z.A. Tuberculosis in Saudi Arabia: prevalence and antimicrobial resistance. JChemother 2012, 24:1-5.
41. Habib A.G., Abdulmumini M., Dalhat M.M., Hamza M., Iliyasu G. Anti-retroviral therapy among HIV infected travelers to Hajj pilgrimage. JTravel Med 2010, 17:176-181.
42. Madani T.A., Albarrak A.M., Alhazmi M.A., Alazraqi T.A., Althaqafi A.O., Ishaq A.H. Steady improvement of infection control services in six community hospitals in Makkah following annual audits during Hajj for four consecutive years. BMC Infect Dis 2006, 6:135.
43. Fauci A.S., Marston lD. The perpetual challenge of antimicrobial resistance. JAMA 2014, 311:1853-1854.
44. Zumla A., Al-Tawfiq J.A., Enne V.I., Kidd M., Drosten C., Breuer J., et al. Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections-needs, advances, and future prospects. Lancet Infect Dis 2014, 14:70827-70828. pii: S1473-3099.
45. Zumla A., Memish Z.A., Maeurer M., Bates M., Mwaba P., Al-Tawfiq J.A., et al. Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options. Lancet Infect Dis 2014, pii: S1473-3099(14)70828-X, [Epub ahead of print]. 10.1016/S1473-3099(14)70828-X.
46. Al-Tawfiq J.A., Zumla A., Gautret P., Gray G.C., Hui D.S., Al-Rabeeah A.A., et al. Surveillance for emerging respiratory viruses. Lancet Infect Dis 2014, 14:992-1000.
47. Woolhouse M., Farrar J. Policy: an intergovernmental panel on antimicrobial resistance. Nature 2014, 509:555-557.
48. Hollis A., Ahmed Z. Preserving antibiotics, rationally. NEngl J Med 2013, 369:2474-2476.
49. Al-Mustafa Z.H., Al-Ghamdi M.S. Use of antibiotics in the poultry industry in Saudi Arabia: implications for public health. Ann Saudi Med 2002, 22(1-2):4-7.
50. Al-Ghamdi M.S., Al-Mustafa Z.H., El-Morsy F., Al-Faky A., Haider I., Essa H. Residues of tetracycline compounds in poultry products in the eastern province of Saudi Arabia. Public Health 2000, 114:300-304.
51. Andersson D.I., Hughes D. Microbiological effects of sublethal levels of antibiotics. Nat Rev Microbiol 2014, 12:465-478.
52. Castanon J.I.R. Review: history of the use of antibiotic as growth promoters in european poultry feeds. Poult Sci 2007, 86:2466-2471.
53. Diarra M.S., Silversides F.G., Diarrassouba F., Pritchard J., Masson L., Brousseau R., et al. Impact of feed supplementation with antimicrobial agents on growth performance of broiler chickens, Clostridium perfringens and Enterococcus number, antibiotic resistant phenotype, and distribution of antimicrobial resistance determinants in E.coli. Appl Environ Microbiol 2007, 73:6566-6576.
54. Diarrassouba F., Diarra M.S., Bach S., Delaquis P., Pritchard J., Topp E., et al. Antibiotic resistance and virulence genes in commensal Escherichia coli and Salmonella isolated from commercial broiler chicken farms. JFood Prot 2007, 70:1316-1327.